Specialized Research Khavinson Bioregulator

Ovagen

Also known as: Peptídeo ovariano

Molecular Identifiers

Molecular Formula

C14H21N3O8

PubChem CID

145455337

Molecular Weight

359.33 Da

Overview

Gastrointestinal tract and reproductive system bioregulatory tripeptide developed by the Khavinson group. Regulates gene expression in the gastrointestinal epithelium and supports ovarian function. Used in short cycles for digestive and reproductive bioregulation.

Sequence (1 letter): EDP
Extended notation: Glu-Asp-Pro

Half-life

~2-4 hours

Administration Route

Subcutaneous or intramuscular

Category

Specialized Research

Mechanism of Action

  • Regulation of gene expression in gastrointestinal epithelium
  • Support for ovarian function and reproductive health
  • Normalization of digestive tract mucosa
  • Modulation of cell renewal in intestinal epithelium
  • Bioregulatory effect on digestive and reproductive systems

Dosage Protocol

Data compiled from the literature. This does not constitute medical advice.

Parameter Value
Dose 5-10 mg per day via subcutaneous injection
Frequency Once daily
Timing Morning or as per protocol
Duration 10-20 days, cycled 2-4 times per year

Reported Side Effects

Adverse effects described in the literature. Severity and frequency vary between individuals.

  • Injection site pain
  • Local redness (rare)

Presentations & Preparation

Vials of Ovagen found in the research market:

10 mg20 mg

Reconstitution

  • Diluent: Bacteriostatic water
  • Volume: 2 ml per vial
  • Inject the diluent slowly against the vial wall
  • Gently swirl until fully dissolved
  • Never shake

Storage

  • Lyophilized: Refrigerated 2-8°C
  • Reconstituted: Refrigerated 2-8°C (up to 30 days)
  • Protect from direct light
  • Do not freeze after reconstitution
Reconstitution Calculator

Scientific Studies

Published studies on Ovagen.

2021 · Molecules

Peptide Regulation of Gene Expression: A Systematic Review

Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR

Related Peptides

Aviptadil

50-150 mcg per administration (IV or subcutaneous) · 1-3 times daily per protocol

B7-33

100-500 mcg per injection (subcutaneous) · Once daily

Bronchogen

5-10 mg per day via subcutaneous injection · Once daily

Cardiogen

5-10 mg per day subcutaneously · Once daily

Chonluten

5-10 mg per day subcutaneously · Once daily

Crystagen

5-10 mg per day via subcutaneous injection · Once daily